This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignee: Mina Therapeutics Limited. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: Siv Anita Hegre: Innovator in saRNA Therapeutics
Introduction
Siv Anita Hegre is a prominent inventor based in Trondheim, Norway. She has made significant contributions to the field of molecular biology, particularly in the development of small activating RNAs (saRNAs). Her innovative work focuses on therapeutic applications that can enhance gene expression, which holds promise for various medical treatments.
Latest Patents
Hegre holds a patent for "SIRT1-saRNA compositions and methods of use." This invention relates to saRNAs that are useful in upregulating the expression of the SIRT1 gene. The patent also includes therapeutic compositions comprising the saRNA, along with methods for utilizing these compositions effectively.
Career Highlights
Siv Anita Hegre is associated with Mina Therapeutics Limited, a company dedicated to advancing RNA-based therapies. Her work at the company emphasizes the potential of saRNA technology in therapeutic settings, showcasing her commitment to innovation in the life sciences.
Collaborations
Hegre collaborates with notable colleagues, including Vikash Reebye and Pinelopi Andrikakou. These partnerships enhance her research efforts and contribute to the advancement of saRNA applications in medicine.
Conclusion
Siv Anita Hegre is a trailblazer in the field of saRNA therapeutics, with a focus on enhancing gene expression for therapeutic purposes. Her contributions through patents and collaborations reflect her dedication to innovation in molecular biology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile